Professor Elizabeth Harry

Liz Harry is Professor of Biology and Director of the ithree institute (infection, immunology and innovation) at the University of Technology Sydney (UTS). Liz is a world leader in the field of bacterial cell division, and partners with industry to develop novel antibiotics, and to identify new ways to fight antibiotic-resistant bacteria. She obtained her PhD in Biochemistry from the University of Sydney. She has been a National Institutes of Health Postdoctoral Fellow at Harvard, an Australian Research Council (ARC) Postdoctoral Fellow and an ARC QEII Fellow, both at the University of Sydney.  Liz joined UTS in 2005 and was promoted to Professor of Biology in 2010. She was the Deputy Director of the ithree institute from 2012-2104, and Acting Director in 2015, prior to becoming Director. Her high quality, innovative research has led her to win the Australian Eureka Prize for Scientific Research in 2002 and the ASM Frank Fenner Award by the Australian Society for Microbiology (ASM) in 2008 in recognition of her distinguished contributions. In 2016, she was included in the SBS list of 6 Six Impressive Aussie Women Scientists.

Session 7 Chair: Alternate therapies
Tuesday 4 April

Supported By